A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer
Latest Information Update: 21 Apr 2023
Price :
$35 *
At a glance
- Drugs Duloxetine (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 21 Mar 2019 Status changed from active, no longer recruiting to completed.
- 12 Mar 2019 Results published in the Cancer
- 07 Nov 2013 New source identified and integrated (Barbara Ann Karmanos Cancer Institute; S1202).